Jonathan Blay Selected Research

Purine Nucleosides

3/2008	Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
11/2006	Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha.
12/2004	Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro.
11/2003	Adenosine stimulation of the proliferation of colorectal carcinoma cell lines. Roles of cell density and adenosine metabolism.
5/2002	Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Blay Research Topics

Disease

23	Neoplasms (Cancer) 12/2022 - 05/2002
10	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2003
7	Carcinoma (Carcinomatosis) 01/2022 - 09/2003
4	Breast Neoplasms (Breast Cancer) 06/2008 - 03/2002
4	Hypoxia (Hypoxemia) 01/2008 - 11/2003
3	Colonic Neoplasms (Colon Cancer) 11/2015 - 05/2002
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2013 - 12/2005
2	Carcinogenesis 05/2007 - 09/2006
2	Mastocytoma 03/2003 - 05/2002
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Leukemia 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Disease Progression 01/2008
1	Inflammation (Inflammations) 01/2008
1	Adenocarcinoma 12/2007
1	Shock 07/2007
1	Type 2 Diabetes Mellitus (MODY) 05/2007
1	Rectal Neoplasms (Rectal Cancer) 05/2007
1	Lymphoma (Lymphomas) 03/2003
1	Apnea 05/2002
1	Necrosis 03/2002

Drug/Important Bio-Agent (IBA)

9	Adenosine (Adenocard)FDA LinkGeneric 03/2008 - 05/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2004
5	Purine NucleosidesIBA 03/2008 - 05/2002
4	Chemokine ReceptorsIBA 11/2015 - 11/2006
3	ApigeninIBA 01/2021 - 04/2011
3	Pharmaceutical PreparationsIBA 12/2017 - 09/2003
3	Fluorouracil (Carac)FDA LinkGeneric 11/2015 - 09/2003
3	ChemokinesIBA 01/2013 - 07/2004
3	PPAR gammaIBA 01/2008 - 05/2007
2	flavoneIBA 01/2021 - 04/2011
2	Chemokine CXCL12IBA 11/2015 - 11/2006
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015 - 04/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2015 - 04/2011
2	Membrane Proteins (Integral Membrane Proteins)IBA 04/2011 - 09/2006
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2008 - 11/2006
2	EicosanoidsIBA 01/2008 - 10/2007
2	NucleosidesIBA 01/2008 - 05/2002
2	Biological ProductsIBA 12/2007 - 07/2007
2	LigandsIBA 11/2006 - 03/2002
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2006 - 07/2004
2	DNA (Deoxyribonucleic Acid)IBA 12/2004 - 11/2003
1	AntiemeticsIBA 12/2022
1	CannabinoidsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	10-N-nonylacridinium orange (NAO)IBA 01/2019
1	Acridine OrangeIBA 01/2019
1	Rhodamine 123IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	dihydroethidiumIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 12/2017
1	Peptide Hydrolases (Proteases)FDA Link 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Cell Adhesion MoleculesIBA 01/2013
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 04/2011
1	Adenosine DeaminaseIBA 04/2011
1	EnzymesIBA 04/2011
1	FlavonoidsIBA 04/2011
1	Potassium Channels (Potassium Channel)IBA 06/2008
1	Ether (Diethyl Ether)IBA 06/2008
1	Imipramine (Janimine)FDA LinkGeneric 06/2008
1	AstemizoleIBA 06/2008
1	Cancer VaccinesIBA 03/2008
1	Peptides (Polypeptides)IBA 01/2008
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2007
1	CXCR4 Receptors (CXCR4 Receptor)IBA 10/2007
1	ProstaglandinsIBA 10/2007
1	Prostaglandins AIBA 10/2007
1	Prostaglandins DIBA 10/2007
1	Prostaglandins EIBA 10/2007
1	Ethanol (Ethyl Alcohol)IBA 07/2007
1	CarbonIBA 07/2007
1	Rosiglitazone (Avandia)FDA Link 05/2007
1	2,4-thiazolidinedione (thiazolidinedione)IBA 05/2007
1	Messenger RNA (mRNA)IBA 11/2006
1	Protein Tyrosine PhosphatasesIBA 09/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2005
1	ThymidineIBA 12/2004
1	GuanosineIBA 07/2004
1	Inosine FDA Link 07/2004
1	Cisplatin (Platino)FDA LinkGeneric 09/2003
1	CeramidesIBA 09/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2003
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2003
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 05/2002
1	integrin alpha4beta7IBA 05/2002
1	IntegrinsIBA 05/2002
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 05/2002
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2002
1	AntibodiesIBA 05/2002
1	Integrin alpha5beta1IBA 05/2002
1	Death Domain ReceptorsIBA 03/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2022 - 03/2002
3	Therapeutics 12/2017 - 01/2008
2	Immunotherapy 03/2008 - 03/2002